Oral supplements for better flu shot response
Part of Immune system & allergy, Infections clinical trials.
This study tests whether taking a daily oral supplement can improve how well the seasonal flu vaccine works in older adults. It aims to see if a simple supplement might help boost immunity after vaccination.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 60 and 70 years old
- You have a body mass index (BMI) between 18.5 and 26.9
- You have not had a flu shot in the past year
- You have not taken certain medications (like lipid-lowering drugs, weight loss drugs, insulin, or steroids) recently
- You have not had other vaccines in the past three months
- You are free from severe chronic illness or recent acute infections
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is a follow-up to an earlier trial. It looks at whether taking a supplement called TUDCA affects how well your body remembers the flu vaccine. If you were in the first study, you may be asked to give a blood sample to check your immune response.
This study gives you a flu vaccine and measures how your immune system reacts, including both “blood immunity” and “cell immunity.” It’s for healthy adults and mainly aims to better understand how well flu vaccines work in people without major health issues.
This study checks how well the seasonal flu vaccine works in people 65 and older who have had flu shots regularly. It compares their immune response to that of younger adults to see if repeated vaccination still protects them.
This trial tests whether a flu vaccine with an extra ingredient (called an adjuvant) is safer and works better for older Asian adults with chronic health conditions than a standard flu vaccine. It aims to provide better protection against the flu for people like you.
This study tests a new seasonal flu shot for people aged 60 and older. It aims to see if the vaccine is safe and how well it produces a protective immune response in older adults.
This trial studies how well your immune system responds to a vaccine in people who are younger adults or, especially, older adults and those with frailty. Your participation may help researchers understand why vaccine responses can differ with age.
Hear when a new Influenza Vaccine Response trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.